EGA Institute for Women's Health, UCL, London, UK
EGA Institute for Women's Health, UCL, London, UK.
BMJ Sex Reprod Health. 2023 Jul;49(3):151-157. doi: 10.1136/bmjsrh-2022-201685. Epub 2023 Jan 19.
Reproductive autonomy-control over outcomes including contraceptive use and childbearing-is a human right and vital to women's empowerment. Those whose reproductive autonomy is threatened by the structures and relationships in their lives are at risk of coercion and unplanned pregnancy and could benefit from additional services. The Reproductive Autonomy Scale (RAS) was developed in the USA to assess women's reproductive autonomy; this study evaluates the RAS for use in the UK.
After testing, the RAS was incorporated into an online survey of women of reproductive age. Those who were sexually active were asked to complete the RAS, which was evaluated according to classical test theory. Reliability was assessed via internal consistency and a 3-month test-retest. Construct validity was assessed using hypothesis testing and confirmatory factor analysis.
For 826 women the RAS was highly acceptable, with a response rate of >97.7%. Almost the whole range of reproductive autonomy scores were captured. Internal consistency was good, with a Cronbach's α of 0.75. Test-retest reliability was fair-good with an intraclass correlation coefficient of 0.67. Construct validity analysis found the scale to be valid based on our hypothesis that among women who want to avoid pregnancy, those with higher reproductive autonomy will be more likely to use contraception. The three-factor structure of the scale was confirmed on confirmatory factor analysis.
The RAS is valid and reliable for use in the UK. This tool holds potential utility across research, clinical practice, health interventions and policy development.
生殖自主权——对包括避孕措施和生育在内的结果的控制——是一项人权,对妇女赋权至关重要。那些其生殖自主权受到生活中的结构和关系威胁的人,可能会面临强制和意外怀孕的风险,并可能受益于额外的服务。生殖自主权量表(RAS)在美国开发,用于评估女性的生殖自主权;本研究评估了 RAS 在英国的使用情况。
经过测试后,RAS 被纳入了一项针对育龄妇女的在线调查。那些有性行为的人被要求完成 RAS,根据经典测试理论对其进行评估。可靠性通过内部一致性和 3 个月的重测信度来评估。结构效度通过假设检验和验证性因素分析进行评估。
对于 826 名女性,RAS 非常易于接受,响应率>97.7%。几乎涵盖了生殖自主权的整个范围。内部一致性良好,Cronbach's α 为 0.75。重测信度为中-高度,组内相关系数为 0.67。结构效度分析基于我们的假设,即对于那些希望避免怀孕的女性,生殖自主权较高的女性更有可能使用避孕措施,发现该量表具有有效性。验证性因素分析证实了该量表的三因素结构。
RAS 在英国具有有效性和可靠性。该工具在研究、临床实践、健康干预和政策制定方面具有潜在的应用价值。